JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,915,000 | -0.7% | 41,900 | -2.6% | 0.20% | -1.0% |
| Q3 2017 | $1,929,000 | +50.1% | 43,000 | 0.0% | 0.20% | +32.9% |
| Q2 2017 | $1,285,000 | +56.5% | 43,000 | +16.2% | 0.15% | +39.4% |
| Q1 2017 | $821,000 | +17.8% | 37,000 | 0.0% | 0.11% | -23.8% |
| Q4 2016 | $697,000 | -37.2% | 37,000 | 0.0% | 0.14% | -28.9% |
| Q3 2016 | $1,110,000 | -21.9% | 37,000 | 0.0% | 0.20% | -25.0% |
| Q2 2016 | $1,422,000 | +0.9% | 37,000 | 0.0% | 0.27% | +4.7% |
| Q1 2016 | $1,409,000 | – | 37,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|